FI801875A7 - 7-(oksoalkyyli)-1,3-dialkyyliksantiinit, niiden valmistusmenetelmä ja näitä yhdisteitä sisältävät lääkeianeet. - Google Patents

7-(oksoalkyyli)-1,3-dialkyyliksantiinit, niiden valmistusmenetelmä ja näitä yhdisteitä sisältävät lääkeianeet. Download PDF

Info

Publication number
FI801875A7
FI801875A7 FI801875A FI801875A FI801875A7 FI 801875 A7 FI801875 A7 FI 801875A7 FI 801875 A FI801875 A FI 801875A FI 801875 A FI801875 A FI 801875A FI 801875 A7 FI801875 A7 FI 801875A7
Authority
FI
Finland
Prior art keywords
dialkylxanthines
oxoalkyl
compounds
preparation
pharmaceutical preparations
Prior art date
Application number
FI801875A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Inventor
Oskar Rohte
GüNTER BRENNER
Joachim Göring
Manfred Tauscher
Eskendar Ali Kahn
Original Assignee
Wuelfing Johann A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2402908A external-priority patent/DE2402908C2/de
Application filed by Wuelfing Johann A filed Critical Wuelfing Johann A
Publication of FI801875A7 publication Critical patent/FI801875A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI801875A 1974-01-22 1975-01-20 7-(oksoalkyyli)-1,3-dialkyyliksantiinit, niiden valmistusmenetelmä ja näitä yhdisteitä sisältävät lääkeianeet. FI801875A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2402908A DE2402908C2 (de) 1974-01-22 1974-01-22 7-(3-Oxobutyl)-1,3-di-(n-butyl)-xanthin und Verfahren zu seiner Herstellung

Publications (1)

Publication Number Publication Date
FI801875A7 true FI801875A7 (fi) 1981-01-01

Family

ID=5905372

Family Applications (2)

Application Number Title Priority Date Filing Date
FI801875A FI801875A7 (fi) 1974-01-22 1975-01-20 7-(oksoalkyyli)-1,3-dialkyyliksantiinit, niiden valmistusmenetelmä ja näitä yhdisteitä sisältävät lääkeianeet.
FI750122A FI59596C (fi) 1974-01-22 1975-01-20 Foerfarande foer framstaellning av en terapeutiskt anvaendbar 7-(3-oxobutyl)-1,3-di-(n-butyl)xantin

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI750122A FI59596C (fi) 1974-01-22 1975-01-20 Foerfarande foer framstaellning av en terapeutiskt anvaendbar 7-(3-oxobutyl)-1,3-di-(n-butyl)xantin

Country Status (13)

Country Link
US (2) US4242345A (en:Method)
JP (1) JPS5912677B2 (en:Method)
AR (1) AR207462A1 (en:Method)
AT (1) AT338286B (en:Method)
BE (1) BE824665A (en:Method)
CA (1) CA1068693A (en:Method)
CH (1) CH608236A5 (en:Method)
FI (2) FI801875A7 (en:Method)
FR (1) FR2258183B1 (en:Method)
GB (1) GB1441562A (en:Method)
HU (1) HU169012B (en:Method)
NL (1) NL184330C (en:Method)
YU (1) YU15175A (en:Method)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2507554A1 (de) * 1975-02-21 1976-09-02 Wuelfing J A Fa 7-(oxoalkyl)-1,3-dialkylxanthine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2507555A1 (de) * 1975-02-21 1976-09-02 Wuelfing J A Fa 7-(oxoalkyl)-1,3-dialkylxanthine, verfahren zu ihrer herstellung und diese verbindung enthaltende arzneimittel
EP0005015B1 (en) * 1978-04-22 1986-10-29 BEECHAM - WUELFING GmbH & Co. KG Use of a xanthine derivate in the manufacture of a medicament
IL59665A0 (en) * 1979-04-05 1980-06-30 Wuelfing J Kg Xanthine derivatives,process for their preparation and their use in pharmaceutical compositions
EP0157098A1 (en) * 1980-06-21 1985-10-09 Beecham Wuelfing GmbH & Co KG Xanthine derivatives, pharmaceuticals compositions containing them and a process for their preparation
GB8418430D0 (en) * 1984-07-19 1984-08-22 Beecham Wuelfing Gmbh & Co Kg Treatment
JPS63225317A (ja) * 1986-10-06 1988-09-20 Hoechst Japan Kk 抗消化性潰瘍剤
US4965271A (en) * 1986-12-31 1990-10-23 Hoechst Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5096906A (en) * 1986-12-31 1992-03-17 University Of Virginia Alumni Patents Foundation Method of inhibiting the activity of leukocyte derived cytokines
JP2661666B2 (ja) * 1988-02-19 1997-10-08 ヘキスト薬品工業株式会社 抗消化性潰瘍剤
GB8826595D0 (en) * 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds
US5321029A (en) * 1988-11-14 1994-06-14 Beecham-Wuelfing Gmbh & Co.K.G. Xanthines
CA2030112A1 (en) * 1989-11-24 1991-05-25 Yasuo Ito Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same
ATE138266T1 (de) * 1990-11-07 1996-06-15 Hoechst Roussel Pharma Verwendung von xanthinen zur herstellung von arzneimitteln zur hemmung der vermehrung menschlicher retroviren
US6420374B1 (en) 1990-11-30 2002-07-16 Fred Hutchinson Cancer Research Center Use of xanthines as immunosuppressants and to inhibit allograft reactions
MX9203323A (es) * 1991-07-11 1994-07-29 Hoechst Ag El empleo de derivados de xantina para el tratamiento de lesiones secundarias de las celulas nerviosas y trastornos funcionales despues de traumas craneo-cerebrales.
TW288977B (en:Method) * 1992-02-22 1996-10-21 Hoechst Ag
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation
US6448235B1 (en) 1994-07-11 2002-09-10 University Of Virginia Patent Foundation Method for treating restenosis with A2A adenosine receptor agonists
US6514949B1 (en) 1994-07-11 2003-02-04 University Of Virginia Patent Foundation Method compositions for treating the inflammatory response
US6232297B1 (en) * 1999-02-01 2001-05-15 University Of Virginia Patent Foundation Methods and compositions for treating inflammatory response
US7427606B2 (en) * 1999-02-01 2008-09-23 University Of Virginia Patent Foundation Method to reduce inflammatory response in transplanted tissue
US7378400B2 (en) * 1999-02-01 2008-05-27 University Of Virginia Patent Foundation Method to reduce an inflammatory response from arthritis
US6322771B1 (en) 1999-06-18 2001-11-27 University Of Virginia Patent Foundation Induction of pharmacological stress with adenosine receptor agonists
US6670334B2 (en) 2001-01-05 2003-12-30 University Of Virginia Patent Foundation Method and compositions for treating the inflammatory response
WO2003029264A2 (en) * 2001-10-01 2003-04-10 University Of Virginia Patent Foundation 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
US7442687B2 (en) * 2004-08-02 2008-10-28 The University Of Virginia Patent Foundation 2-polycyclic propynyl adenosine analogs having A2A agonist activity
CA2576826C (en) * 2004-08-02 2014-09-30 University Of Virginia Patent Foundation 2-propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity
US7576069B2 (en) * 2004-08-02 2009-08-18 University Of Virginia Patent Foundation 2-polycyclic propynyl adenosine analogs having A2A agonist activity
US8178509B2 (en) * 2006-02-10 2012-05-15 University Of Virginia Patent Foundation Method to treat sickle cell disease
US8188063B2 (en) 2006-06-19 2012-05-29 University Of Virginia Patent Foundation Use of adenosine A2A modulators to treat spinal cord injury
US8058259B2 (en) 2007-12-20 2011-11-15 University Of Virginia Patent Foundation Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2756229A (en) * 1956-07-24 Xanthine derivatives
CA557342A (en) 1958-05-13 Doebel Karl Process for the manufacture of novel xanthine derivatives
US2761863A (en) * 1956-09-04 Lower-alkyl
FR4791E (fr) 1900-06-29 1905-10-16 Eugene Fournier Lampe à pétrole perfectionnée pour chauffage intensif dite: "la naphteuse"
DE926788C (de) 1952-11-07 1955-04-25 Geigy Ag J R Verfahren zur Herstellung von 1, 3-dialkylierten 7-Oxyalkyl-xanthinabkoemmlingen
GB759174A (en) * 1952-11-07 1956-10-17 Geigy Ag J R Improvements in diuretic acting xanthine derivatives
GB759981A (en) * 1953-09-09 1956-10-24 Roche Products Ltd Process for the manufacture of xanthine derivatives
CH325292A (de) 1953-10-21 1957-10-31 Geigy Ag J R Verfahren zur Herstellung von 7-Oxyalkyl-xanthinderivaten
US3737433A (en) * 1964-09-05 1973-06-05 Albert Ag Chem Werke Certain oxoalkyldimethylxanthines
DE2234202A1 (de) 1972-07-12 1974-01-24 Albert Ag Chem Werke Verfahren zur herstellung von oxoalkylxanthinen
DE2330742C2 (de) * 1973-06-16 1982-07-29 Hoechst Ag, 6000 Frankfurt 1-(Oxoalkyl)-3-methyl-7-alkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2457666A1 (de) * 1974-12-06 1976-06-10 Hoechst Ag Arzneimittel, verfahren zur herstellung von dafuer geeigneten wirkstoffen und diese oxoalkyl-dialkyl-xanthine
JPS5233120A (en) * 1975-09-10 1977-03-14 Nisshin Steel Co Ltd Double coiled automobile steel pipe covered with heat flexible plastic resin

Also Published As

Publication number Publication date
US4242345A (en) 1980-12-30
HU169012B (en:Method) 1976-08-28
YU15175A (en) 1982-06-30
ATA929674A (de) 1976-12-15
NL184330B (nl) 1989-01-16
JPS50101386A (en:Method) 1975-08-11
FR2258183B1 (en:Method) 1978-07-28
GB1441562A (en) 1976-07-07
FI59596C (fi) 1981-09-10
US4291037A (en) 1981-09-22
AT338286B (de) 1977-08-10
AR207462A1 (es) 1976-10-08
CH608236A5 (en:Method) 1978-12-29
FI750122A7 (en:Method) 1975-07-23
NL184330C (nl) 1989-06-16
NL7414887A (nl) 1975-07-24
JPS5912677B2 (ja) 1984-03-24
FI59596B (fi) 1981-05-29
BE824665A (fr) 1975-05-15
FR2258183A1 (en:Method) 1975-08-18
CA1068693A (en) 1979-12-25

Similar Documents

Publication Publication Date Title
FI801875A7 (fi) 7-(oksoalkyyli)-1,3-dialkyyliksantiinit, niiden valmistusmenetelmä ja näitä yhdisteitä sisältävät lääkeianeet.
NL7514012A (nl) Farmaceutische capsules.
NL7510342A (nl) Gesubstitueerde purineverbindingen en farmaceu- tische toepassing daarvan.
NL7500552A (nl) Farmaceutische preparaten.
NL7608856A (nl) Werkwijze ter bereiding van nieuwe tetrahydro- isochinoline derivaten alsmede deze verbindingen bevattende farmaceutische preparaten.
NL980035I1 (nl) Benzimidazolen, de bereiding daarvan en deze verbindingen bevattende geneesmiddelen.
NL7706301A (nl) Farmaceutisch inbrengpreparaat en werkwijze ter bereiding daarvan.
IL48592A (en) 1-substituted-4-benzypiperidine derivatives,their preparation and pharmaceutical composistions comprising them
FI792009A7 (fi) 3-aminopropoksiaryylijohdannaisia, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset.
FI802808A7 (fi) Uusia tetraliini-johdannaisia, niiden valmistus ja farmaseuttisia valmisteita, jotka sisältävät näitä yhdistyhdisteitä.
NL7509080A (nl) Farmaceutisch preparaat en werkwijze ter bereiding ervan.
NL7510535A (nl) Werkwijze ter bereiding van nieuwe arylpiperi- dinen, alsmede werkwijze ter bereiding van farmaceutische preparaten.
NL7609414A (nl) Werkwijze ter bereiding van farmaceutische preparaten en werkwijze ter bereiding van 1-sulfonylbenzimidazoolderivaten.
FI812810A7 (fi) Ammoniometyyliyhdisteitä, menetelmiä niiden valmistamiseksi, näitä yhdisteitä sisältäviä farmaseuttisia valvalmisteita ja viimemainittujen käyttö.
IL42311A0 (en) Cyclic sulphur compounds,their preparation and pharmaceutical preparations containing them
FI791639A7 (fi) Uusia imidatsolijohdannaisia, menetelmiä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia valmisteita.
NL7505240A (nl) Farmaceutisch preparaat.
NL7603012A (nl) Nitrofurylpyrazoolderivaten, werkwijzen ter berei- ding daarvan en geneesmiddelen, die deze verbin- dingen bevatten.
FI803356A7 (fi) Uudet atsepinoindolit, niiden valmistus ja niitä sisältävät farmaseuttiset yhdisteet.
FI793375A7 (fi) Antikoagulantti, menetelmä sen valmistamiseksi ja sitä sisältävät farmaseuttiset valmisteet.
NL7514337A (nl) Oxydiaceetaldehyde bevattende preparaten en werk- wijzen ter bereiding ervan.
NL172240C (nl) Werkwijze om pteridinederivaten te bereiden en farmaceutische preparaten, welke deze verbindingen bevatten.
FI792597A7 (fi) Uusia N-fenyyli-indoliinijohdannaisia, niiden valmistus ja aineet, jotka sisältävät näitä yhdisteitä.
NL7508706A (nl) Werkwijze ter bereiding van pyrazofurinederivaten, alsmede werkwijze ter bereiding van farmaceutische preparaten.
NL7514113A (nl) Werkwijze ter bereiding van farmaceutische prepa- raten, gevormde farmaceutische preparaten, alsme- de werkwijze ter bereiding van nieuwe cefemverbin- dingen.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: WUELFING, JOHANN A.